Jiangmen Shuotong Medical Technology Co., Ltd. was established in 2012, a period marked by the vigorous development of China's medical technology sector. As a national high-tech enterprise, the company has always adhered to its mission of “dedicating to the advancement of medical technology and contributing to human health.” Specializing in the field of urological stones, Shuotong Medical continuously engages in technological innovation and precision manufacturing to provide safe, reliable, and efficient urological stone solutions for medical institutions worldwide.

Headquartered in Jiangmen, Guangdong—a key city within the Guangdong-Hong Kong-Macao Greater Bay Area—the company operates a modern R&D and production base spanning 2,200 square meters. The facility is equipped with a 100,000-class clean production workshop and internationally advanced intelligent manufacturing systems. Supported by a professional R&D team and a collaborative innovation platform integrating medicine and engineering, the company has established a comprehensive quality management system covering the entire product lifecycle. It has obtained ISO 13485 Medical Device Quality Management System certification as well as ISO triple system certification, demonstrating its internationally recognized quality control capabilities.

As a technology pioneer in the urological stone field, Shuotong Medical has built a synergistic innovation system integrating “industry, academia, research, and application,” leading to the transformation of multiple breakthrough technological achievements. Its self-developed Shuotong Scope product series innovatively enables synchronous stone fragmentation and clearance, overcoming the efficiency limitations of traditional surgical methods. This technology has not only been included in the *Chinese Urological Disease Diagnosis and Treatment Guidelines* but has also been incorporated into the stone management guidelines of the European Association of Urology (EAU). It is the first domestically developed stone clearance system to be included in an international authoritative guideline, signifying that Chinese innovation has achieved world-leading status in the field of urology.

After more than a decade of dedicated development guided by the principles of “rigor, pragmatism, innovation, and growth,” Shuotong Medical has established a technical service network that spans across China. Its products are used in over 1,000 medical institutions domestically and are exported to numerous countries and regions.

In this new era of medical technology advancement, Shuotong Medical is accelerating its global expansion, deepening strategic collaborations with top-tier medical institutions and research organizations, and promoting integrated innovation between medicine and engineering. Moving forward, the company will continue to increase investment in R&D, focusing on breakthroughs in intelligent minimally invasive technologies. It is committed to becoming a global innovation benchmark in the urological field and contributing Chinese expertise to building a global community of health for all.